298 related articles for article (PubMed ID: 3901330)
21. Characterization of two monoclonal antibodies against secretory proteinase of Candida tropicalis DSM 4238.
Borg-von Zepelin M; Grüness V
J Med Vet Mycol; 1993; 31(1):1-15. PubMed ID: 8483055
[TBL] [Abstract][Full Text] [Related]
22. Human, monoclonal and recombinant candidacidal, pneumocysticidal and mycobactericidal antibodies.
Polonelli L
Indian J Chest Dis Allied Sci; 2000; 42(4):259-63. PubMed ID: 15597672
[TBL] [Abstract][Full Text] [Related]
23. Protective immunity against murine candidiasis elicited by Candida albicans ribosomal fractions.
Levy R; Segal E; Eylan E
Infect Immun; 1981 Mar; 31(3):874-8. PubMed ID: 7014464
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
[TBL] [Abstract][Full Text] [Related]
25. Vaccines against fungal infections.
Segal E
Crit Rev Microbiol; 1987; 14(3):229-71. PubMed ID: 3556019
[TBL] [Abstract][Full Text] [Related]
26. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
[TBL] [Abstract][Full Text] [Related]
27. Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice.
Wang G; Sun M; Fang J; Yang Q; Tong H; Wang L
Vaccine; 2006 Aug; 24(35-36):6065-73. PubMed ID: 16842891
[TBL] [Abstract][Full Text] [Related]
28. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
Xin H
Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
[TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
Ibrahim el-SM; Rahman AK; Isoda R; Umeda K; Van Sa N; Kodama Y
Vaccine; 2008 Apr; 26(17):2073-80. PubMed ID: 18375022
[TBL] [Abstract][Full Text] [Related]
30. Non-lethal Candida albicans cph1/cph1 efg1/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells.
Yang YL; Wang CW; Chen CT; Wang MH; Hsiao CF; Lo HJ
Mycol Res; 2009 Mar; 113(Pt 3):388-90. PubMed ID: 19111931
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.
Li W; Hu Y
Methods Mol Biol; 2017; 1625():313-326. PubMed ID: 28584999
[TBL] [Abstract][Full Text] [Related]
32. Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.
Martínez-López R; Nombela C; Diez-Orejas R; Monteoliva L; Gil C
Proteomics; 2008 Jul; 8(13):2651-64. PubMed ID: 18546157
[TBL] [Abstract][Full Text] [Related]
33. Strain differences in the severity of lesions in murine systemic candidiasis correlate with the production of functional gamma interferon by Candida-activated lymphocytes in vitro.
Ashman RB; Bolitho EM
Lymphokine Cytokine Res; 1993 Dec; 12(6):471-6. PubMed ID: 8123764
[TBL] [Abstract][Full Text] [Related]
34. Cell-mediated immunity following experimental vaccinations with Candida albicans ribosomes.
Levy R; Segal E; Eylan E; Barr-Nea L
Mycopathologia; 1983 Nov; 83(3):161-8. PubMed ID: 6366570
[TBL] [Abstract][Full Text] [Related]
35. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
36. Enhanced resistance against systemic Candida albicans infection in mice treated with C. albicans DNA.
Dimitrova P; Yordanov M; Danova S; Ivanovska N
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):231-6. PubMed ID: 18507679
[TBL] [Abstract][Full Text] [Related]
37. Induction of salivary antibodies to inhibit Candida albicans adherence to human epithelial cells by tonsillar immunization in rabbits.
Fukuizumi T; Nagamatsu H; Kojo T; Inoue H
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):398-404. PubMed ID: 16872376
[TBL] [Abstract][Full Text] [Related]
38. B cell-independent selection of memory T cells after mucosal immunization with Candida albicans.
Jones-Carson J; Vazquez-Torres FA; Balish E
J Immunol; 1997 May; 158(9):4328-35. PubMed ID: 9126995
[TBL] [Abstract][Full Text] [Related]
39. Humoral and cell-mediated immunity following vaccination with synthetic Candida cell wall mannan derived heptamannoside-protein conjugate: immunomodulatory properties of heptamannoside-BSA conjugate.
Paulovičová L; Paulovičová E; Karelin AA; Tsvetkov YE; Nifantiev NE; Bystrický S
Int Immunopharmacol; 2012 Oct; 14(2):179-87. PubMed ID: 22835427
[TBL] [Abstract][Full Text] [Related]
40. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms.
Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
